It’s been just reported that the latest investment in lung cancer research related to women has a massive impact on the US economy. Here’s why this is important.
Latest medical investments in the US
Medical Press notes that the funding for research focused on women and lung cancer has doubled, and this move will have enormous economic impacts for families and the nation, according to a new report released today by Women’s Health Access Matters (WHAM), which commissioned The RAND Corporation to create this study on lung cancer in women.
It’s also been revealed that according to rigorous modeling based on a number of conservative estimates, even health improvements of 0.1 percent in mortality and quality of life will yield a return on investment of $1,200 for every additional dollar spent.
The same source mentioned above notes the fact that today’s findings mirror three previous studies from WHAM.
It’s important to note the fact that these were executed by The RAND Corporation. More than that, they are showing similar findings with respect to the power of investment for women’s health research associated with Alzheimer’s disease, heart disease, and rheumatoid arthritis.
Lung cancer research
For lung cancer, this is extremely important because in the U.S., lung cancer is the number one cause of cancer death in women.
It’s been unfortunately revealed that more women die of lung cancer (it’s been revealed that approximately 61,000 in 2022, according to CA: A Cancer Journal for Clinicians) than of breast, ovarian and cervical cancers combined.
More than that, according to the latest reports, it seems that non-smoking women are more than two times as likely to get lung cancer as their male counterparts. We suggest that you check out the official data in order to learn more details about such an important issue. Stay tuned for more news from the healthcare space.